The cholesterol paradox in heart failure. (Q37018475)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18046092%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

review article

1 reference

title

The cholesterol paradox in heart failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18046092%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18046092%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18046092%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Poay Huan Loh

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18046092%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Andrew Clark

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18046092%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

1 November 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18046092%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

published in

Congestive Heart Failure

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18046092%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18046092%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18046092%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

336-341

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18046092%20AND%20SRC:MED&resulttype=core&format=json

Recognising the limits of randomized clinical trials.

28 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Statins and mortality among elderly patients hospitalized with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

The effects of initiation or continuation of statin therapy on cholesterol level and all-cause mortality after the diagnosis of left ventricular systolic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Statin therapy and risks for death and hospitalization in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

The endotoxin-lipoprotein hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Statins in heart failure. Beyond the lipid lowering effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Statins for heart failure: at the crossroads between cholesterol reduction and pleiotropism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Statin therapy is associated with improved cardiovascular outcomes and levels of inflammatory markers in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Atorvastatin therapy increases heart rate variability, decreases QT variability, and shortens QTc interval duration in patients with advanced chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the Treating to New Targets (TNT) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Preservation of NO production by statins in the treatment of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Endothelium-ameliorating effects of statin therapy and coenzyme Q10 reductions in chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Statins initiated after hypertrophy inhibit oxidative stress and prevent heart failure in rats with aortic stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Effects of atorvastatin on reactive hyperaemia and the thrombosis-fibrinolysis system in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors prevent the development of cardiac hypertrophy and heart failure in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Pravastatin increases survival and suppresses an increase in myocardial matrix metalloproteinase activity in a rat model of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Double-blind, randomized, placebo-controlled study of high-dose HMG CoA reductase inhibitor therapy on ventricular remodeling, pro-inflammatory cytokines and neurohormonal parameters in patients with chronic systolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Do statins have an antiarrhythmic activity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Catabolism in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

The relationship between cholesterol and survival in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Inverse association between lipid levels and mortality in men with chronic kidney disease who are not yet on dialysis: effects of case mix and the malnutrition-inflammation-cachexia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Nutritional abnormalities contributing to cachexia in chronic illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Statin use and survival in patients with chronic heart failure--results from two observational studies with 5200 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

The role of coenzyme Q10 in statin-associated myopathy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Statin therapy is associated with lower mortality among patients with severe heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Trends in Heart Failure Incidence and Survival in a Community-Based Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Obesity and heart failure prognosis: paradox or reverse epidemiology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X

Response to Letter Regarding Article “Effect Size Estimates of Lifestyle and Dietary Changes on All-Cause Mortality in Coronary Artery Disease Patients: A Systematic Review”

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2007.07211.X